Effect of the BET Protein Inhibitor, RVX-208, on Progression of Coronary Atherosclerosis: Results of the Phase 2b, Randomized, Double-Blind, Multicenter, ASSURE Trial

被引：0
|
作者：
Stephen J. Nicholls
Rishi Puri
Kathy Wolski
Christie M. Ballantyne
Philip J. Barter
H. Bryan Brewer
John J. P. Kastelein
Bo Hu
Kiyoko Uno
Yu Kataoka
Jean-Paul R. Herrman
Bela Merkely
Marilyn Borgman
Steven E. Nissen
机构：
[1] South Australian Health and Medical Research Institute,Department of Cardiovascular Medicine and Cleveland Clinic Coordinating Center for Clinical Research
[2] Cleveland Clinic,Section of Cardiovascular Research
[3] Baylor College of Medicine and the Methodist DeBakey Heart and Vascular Center,Department of Vascular Medicine, Academic Medical Center
[4] University of New South Wales,Department of Cardiology
[5] Medstar Research Institute,Heart and Vascular Center
[6] University of Medicine,undefined
[7] Onze Lieve Vrouwe Gasthuis,undefined
[8] Semmelweis University,undefined
来源：
American Journal of Cardiovascular Drugs | 2016年 / 16卷
关键词：
Atorvastatin; Rosuvastatin; Plaque Burden; Interactive Voice Response; Incremental Benefit;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：55 / 65
页数：10
相关论文
共 50 条
  • [31] Denosumab in transfusion-dependent thalassemia osteoporosis: a randomized, placebo-controlled, double-blind phase 2b clinical trial
    Voskaridou, Ersi
    Ntanasis-Stathopoulos, Ioannis
    Papaefstathiou, Athanasios
    Christoulas, Dimitrios
    Dimopoulou, Maria
    Repa, Konstantina
    Papatheodorou, Athanasios
    Peppa, Melpomeni
    Terpos, Evangelos
    BLOOD ADVANCES, 2018, 2 (21) : 2837 - 2847
  • [32] ICOSABUTATE IN NASH/MASH WITH FIBROSIS: RESULTS FROM A RANDOMISED, MULTICENTRE, DOUBLE-BLIND, PLACEBO CONTROLLED, PHASE 2b TRIAL (ICONA)
    Harrison, Stephen A.
    Alkhouri, Naim
    Benun, Jacques
    Ortiz-Lasanta, Grisell
    Rudraraju, Madhavi
    Steineger, Hilde H.
    Fraser, David
    Sanyal, Arun J.
    HEPATOLOGY, 2024, 79 (02) : E44 - E45
  • [33] BIO101 in Sarcopenic Seniors at Risk of Mobility Disability: Results of a Double-Blind Randomised Interventional Phase 2b Trial
    Fielding, Roger A.
    Dao, Michael M.
    Cannon, Kevin
    Desvarieux, Moise
    Miller, Sam S.
    Gimness, Michael Paul
    Brandon, Donald M.
    Villareal, Dennis T.
    Bruyere, Olivier
    Bautmans, Ivan
    Rickner, Kyle
    Perry, Robert
    Kritchevsky, Stephen B.
    Musi, Nicolas
    Chehade, Joe M.
    Kirstein, Judith L.
    Gielen, Evelien
    Pickrell, Paul
    Dilda, Pierre
    Lafont, Rene
    Margalef, Carole
    Rolland, Yves
    Del Signore, Susanna
    Mariani, Jean
    Agus, Samuel
    Tourette, Cendrine
    Dioh, Waly
    van Maanen, Rob
    Veillet, Stanislas
    JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2025, 16 (02)
  • [34] Telitacicept in patients with active systemic lupus erythematosus: results of a phase 2b, randomised, double-blind, placebo-controlled trial
    Wu, Di
    Li, Jing
    Xu, Dong
    Merrill, Joan T.
    van Vollenhoven, Ronald F.
    Liu, Yi
    Hu, Jiankang
    Li, Yang
    Li, Fen
    Huang, Chenghui
    Wang, Guochun
    Li, Xiaomei
    Zhao, Jianhong
    Zhao, Dongbao
    Huang, Cibo
    Liu, Huaxiang
    Wei, Wei
    Shi, Guixiu
    Lu, Fuai
    Zuo, Xiaoxia
    Bi, Liqi
    Li, Zhijun
    Wang, Xiaoxia
    Zhang, Miaojia
    Tie, Ning
    Li, Juan
    Mo, Hanyou
    Fang, Jianmin
    Bao, Chunde
    Zhang, Fengchun
    ANNALS OF THE RHEUMATIC DISEASES, 2024, 83 (04) : 475 - 487
  • [35] Oral JZP-110 phase 2b study for the treatment of excessive sleepiness in adults with narcolepsy: Results of a randomized, double-blind, placebo-controlled trial
    Black, J.
    Swick, T.
    Feldman, N.
    Doekel, R., Jr.
    Khayrallah, M.
    Bream, G.
    Ruoff, C.
    SLEEP MEDICINE, 2015, 16 : S36 - S36
  • [36] Response to letter regarding article, "Effect of intensive versus standard lipid-lowering treatment with atorvastatin on the progression of calcified coronary atherosclerosis over 12 months:: A multicenter, randomized, double-blind trial"
    Schmermund, Axel
    Siffert, Winfried
    Erbel, Raimund
    Achenbach, Stephan
    Budde, Thomas
    Kerkhoff, Gert
    Buziashvili, Yuri
    Foerster, Andreas
    Friedrich, Guy
    Henein, Michael
    Knollmann, Friedrich
    Kukharchuk, Valery
    Lahiri, Avijit
    Leischik, Roman
    Moshage, Werner
    Schartl, Michael
    Steinhagen-Thiessen, Elisabeth
    Vogt, Anja
    Sinitsyn, Valentin
    Wiedeking, Burkhard
    CIRCULATION, 2006, 114 (12) : E507 - E508
  • [37] Measures of Functioning in Patients With Episodic Migraine: Findings From a Double-Blind, Randomized, Placebo-Controlled Phase 2b Trial With Galcanezumab
    Ayer, David W.
    Skljarevski, Vladimir
    Ford, Janet H.
    Nyhuis, Allen W.
    Lipton, Richard B.
    Aurora, Sheena K.
    HEADACHE, 2018, 58 (08): : 1225 - 1235
  • [38] A PHASE 2B DOUBLE-BLIND PLACEBOCONTROLLED RANDOMIZED CLINICAL TRIAL OF SB-061, AN AGGRECAN MIMETIC, IN SUBJECTS WITH SYMPTOMATIC KNEE OSTEOARTHRITIS
    Bihlet, A. R.
    Byrjalsen, I.
    Mundbjerg, K.
    Alexandersen, P.
    Rovsing, H.
    Axelsen, T.
    Andersen, J. R.
    Metnik, A.
    Bachtell, N.
    Brett, A.
    Christiansen, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 265 - 266
  • [39] Effect of atorvastatin on progression of sensorineural hearing loss and tinnitus in the elderly:: Results of a prospective, randomized, double-blind clinical trial
    Olzowy, Bernhard
    Canis, Martin
    Hempel, John-Martin
    Mazurek, Birgit
    Suckfuell, Markus
    OTOLOGY & NEUROTOLOGY, 2007, 28 (04) : 455 - 458
  • [40] Ongoing clinical trial: PESTO, a prospective multicenter, phase 2b randomized controlled double-blind trial, to determine the safety and efficacy of perispinal etanercept on quality of life at 28 days post treatment
    Thijs, V
    Bernhardt, J.
    Churilov, L.
    Sprigg, N.
    Cloud, G.
    Parsons, B.
    Jafari, S.
    Walker, M.
    Gilchrist, N.
    Bath, P.
    INTERNATIONAL JOURNAL OF STROKE, 2021, 16 (1_SUPPL) : 30 - 30
12345